NEW YORK, June 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The one-stop online business resource for everyone involved in this high-growth area.
Interest in cancer has never been greater as drug developers pursue a vast range of therapeutic approaches to find effective treatments for one of the world's biggest killers.
Cancer Analysis is a daily-updated online business resource from Espicom. When research time is at a premium, executives need fast access to reliable business information. Having that information in a single daily-updated and easy to search online service brings untold time and efficiency savings.
Cancer Analysis provides:
Company Performance, Products and Research Pipelines
Regularly updated and detailed analysis of over 120 leading companies' strategy, research, products and agreements.
Conference and Meeting Reviews
A distillation of the important news from leading meetings such as ASCO and AACR.
R&D and Product Developments
R&D and product developments in all major cancer areas.
Latest News
Track the research, performance and developments of over 1,700 companies and organisations involved with cancer drugs worldwide.
Companies covered in Cancer Analysis: Access Pharmaceuticals
Active Biotech
ADVENTRX Pharmaceuticals
AEterna Zentaris
Agennix
Alchemia
Allos Therapeutics
Ambrilia Biopharma
Amgen
Agenus
Antisense Pharma
Antisoma
ARIAD Pharmaceuticals
Ark Therapeutics
ArQule
Array BioPharma
AstraZeneca
AVAX Technologies
Bayer
Biogen Idec
BioNumerik Pharmaceuticals
Bristol-Myers Squibb
BTG
Can-Fite BioPharma
CEL-SCI
Celgene
Cell Therapeutics
Cephalon
Clavis Pharma
Cyclacel Pharmaceuticals
Daiichi Sankyo
Dendreon
Eisai
Eli Lilly
Endocyte
EntreMed
Enzon Pharmaceuticals
EpiCept
Exelixis
Gamida Cell
Genmab
Genta
GenVec
Genzyme Oncology
Geron
GlaxoSmithKline
Human Genome Sciences
Idera Pharmaceuticals
ImmunoGen
Immunomedics
Isis Pharmaceuticals
Keryx Biopharmaceuticals
Kyowa Hakko Kirin
Ligand Pharmaceuticals
Lorus Therapeutics
Marshall Edwards
MediGene
Merck KGaA
MethylGene
Micromet
INSYS Therapeutics
Northwest Biotherapeutics
Novartis
OncoGenex Technologies
Oncolytics Biotech
Onyvax
Onyx Pharmaceuticals
OSI Pharmaceuticals
Oxford BioMedica
OXiGENE
Peregrine Pharmaceuticals
Pfizer
Pharmacyclics
PharmaMar
Photocure
Progen Pharmaceuticals
Progenics Pharmaceuticals
Quest PharmaTech
Roche
sanofi-aventis
Seattle Genetics
Spectrum Pharmaceuticals
SuperGen
Synta Pharmaceuticals
Talon Therapeutics
Tamir Biotechnology
Tekmira Pharmaceuticals
Telik
TopoTarget
Transgene
Vical
Vion Pharmaceuticals
Viventia Biotech
Wilex
YM BioSciences
Cancer Analysis is available 24/7 worldwide from any PC with an Internet connection. In addition to rapidly updated independent content, Cancer Analysis customers benefit from the easy-to-use interface, simple but powerful search facility and practical features, such as being able to copy and paste information for use in internal plans, documents and presentations. Cancer Analysis is ideal for single users or as a whole enterprise information solution with a range of flexible distribution packages.
To order this report:
Pathology Industry: Cancer Analysis
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker